[Serum angiogenin concentration in nasopharyngeal carcinoma patients and its clinical significance].
To determine the serum angiogenin (ANG) concentration in patients with nasopharyngeal carcinoma (NPC) and analyze its clinical significance. Forty-two NPC patients and 30 healthy controls entered this study. Serum ANG level was quantitatively analyzed by enzyme-linked immunosorbent assay (ELISA). The mean level of serum ANG in untreated NPC was (371.4 +/- 123.5) microg/L, which was significantly higher than that in healthy controls(292.5 +/- 74.2) microg/L (P < 0.01). Furthermore, the serum level of ANG increased with the development of tumor (P < 0.05). After treatment, all patients reached a response: partial response (PR) or complete response (PR), and the serum ANG level was (340.6 +/- 112.4) microg/L, which was significantly lower than that in untreated ones (P < 0.05), but still higher than that in healthy controls (P < 0.05). Our results indicate that the serum ANG level increases in patients with NPC, and is correlate with primary tumor progression.